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Available online 28 March 2016Hypobaric Hypoxia (HH) is an established risk factor for various neuro-physiological perturbations including
cognitive impairment. The origin andmechanistic basis of such responses however remain elusive.Wehere com-
bined systems level analysis with classical neuro-physiological approaches, in a rat model system, to understand
pathological responses of brain toHH. Unbiased ‘statistical co-expression networks’ generatedutilizing temporal,
differential transcriptome signatures of hippocampus—centrally involved in regulating cognition—implicated
perturbation of Glio-Vascular homeostasis during early responses to HH, with concurrent modulation of
vasomodulatory, hemostatic and proteolytic processes. Further, multiple lines of experimental evidence from
ultra-structural, immuno-histological, substrate-zymography and barrier function studies unambiguously sup-
ported this proposition. Interestingly, we show a signiﬁcant lowering of H2S levels in the brain, under chronic
HH conditions. This phenomenon functionally impacted hypoxia-induced modulation of cerebral blood ﬂow
(hypoxic autoregulation) besides perturbing the strength of functional hyperemia responses. The augmentation
of H2S levels, during HH conditions, remarkably preserved Glio-Vascular homeostasis and key neuro-
physiological functions (cerebral blood ﬂow, functional hyperemia and spatial memory) besides curtailing HH-
induced neuronal apoptosis in hippocampus. Our data thus revealed causal role of H2S during HH-induced
early Glio-Vascular dysfunction and consequent cognitive impairment.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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H2S1. Introduction
Amongst various organ systems, central nervous system (CNS) is
highly vulnerable to hypoxic insult, owing to its high-energy require-
ments (Ladecola, 2013) and thus, ensuing risk of compromised function
(Wilson et al., 2009). Several pathological states including asphyxia,
stroke, head injury besides environmental conditions, such as those en-
countered at high altitude, culminate in reduced oxygen availability to
brain cells (Wilson et al., 2009). Hypobaric Hypoxia (HH) resulting
from reduction in the effective concentration of inspired Oxygen, due
to decreased atmospheric pressure (with ascent to high altitude), cul-
minates into various neuro-pathological conditions including distinc-
tive cognitive impairment. Given the systemic nature of stress induced
by HH, while it is conceivable that the neuro-pathological effects
under these conditions are cumulative manifestations of tissue-Division, Defence Institute of
Road, Timarpur, Delhi 110054,
.
. This is an open access article underspeciﬁc (brain) responses and paracrine factors of distant tissue origin
(secreted in plasma); the precise molecular, patho-etiological basis of
such effects remain elusive. It is noteworthy that besides an immediate
relevance for well being at altitude; research in this area promises a
unique opportunity to decipher facts, which can also be applied to crit-
ical care medicine (Grocott et al., 2007). For such reasons, thus, the
mechanistic understanding of this phenomenon has remained the
Holy Grail for numerous basic and clinical researchers across the globe
since several decades.
The early phases of HH-induced physiological response result in the
activation of various adaptive measures at systemic (Imray et al., 2010;
Teppema and Dahan, 2010; West et al., 2007), cellular and metabolic
levels (Harik et al., 1995). The chronic exposure, however, culminates
in conspicuous pathological outcomes related to brain, ranging from
moderate to severe forms, in a time- and exposure-dependent manner
(Bartsch and Swenson, 2013; Dehnert et al., 2007; Hackett and Roach,
2004; Imray et al., 2010; Sylvester et al., 2012; Willmann et al., 2014;
Yan, 2014). The moderate neurological effects of sustained HH include
Acute Mountain Sickness (AMS), insomnia, dizziness and alteration of
mood (Hackett and Roach, 2001; Wilson et al., 2009) while the severethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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conditions such as long term impairment of psychomotor (Bouquet
et al., 1999; Virues-Ortega et al., 2004) and cognitive functions
(Kramer et al., 1993; Yan, 2014) besides dire, life threatening conse-
quences arising from high altitude cerebral edema (HACE) (Hackett
and Roach, 2004; Hackett et al., 1998; Schommer et al., 2013;
Willmann et al., 2014; Wilson et al., 2009).
The neuro-pathological alterations in response to HH are variously
attributed to oxidative stress (Maiti et al., 2006), modulation of cholin-
ergic markers (Muthuraju et al., 2011), excitotoxicity (Hota et al., 2008;
Mark et al., 2001) and dendritic atrophy in hippocampal pyramidal neu-
rons (Titus et al., 2007). Notably, however, the molecular mechanistic
basis of HH-induced changes in neurophysiology and ensuing cognitive
impairments is grossly lacking. We here utilized a rat model system of
HHand performed temporal, genome-wide expression proﬁling follow-
ed by unbiased statistical networking in conjunction with biological
pathwaymining strategies to infer chronology of physiological/molecu-
lar perturbations during HH-induced neuro-pathological effects. Our
data yielded unambiguous evidence for the perturbation of Glio-
Vascular units during early response to HH, which progressed tomodu-
late Neuro- vascular unit function and cognitive impairment. We impli-
cate complex molecular circuitry involving modulation of multiple
regulators of Calcium sensitivity and vascular homeostasis prior to dis-
ruption of such basic ‘units of function’ in the brain. Interestingly, we
show thatmarked reduction in H2S levels in the brain causally governed
neuro-vascular dysfunction and ensuing pathophysiological effects of
HH.
2. Materials and Methods
2.1. Animal Experiments and Ethics Statement
Male Sprague Dawley rats weighing 225–250 g were used for the
study. The animalsweremaintained in animal house facility of the insti-
tute and were exposed to 12 h each of light–dark cycle. The animals
were fedwith pellet diet andwater ad libitum. The study designwas ap-
proved by the standing ‘Institute Animal Ethics Committee’ of Defence
Institute of Physiology andAllied Sciences (DIPAS), Delhi and the exper-
iments were conducted in strict compliance with the guidelines of
‘Committee for the Purpose of Control and Supervision of Experiments
on Animals (CPCSEA)’, Government of India.
2.2. High Altitude Simulation (Hypobaric Hypoxia Exposure)
The animals were exposed to simulated-high altitude (Hypobaric
Hypoxia, HH) in a specially designed animal decompression chamber
to maintain a constant pressure of 282 Torr (equivalent to an altitude
of 7620m, 8%O2). The rate of ascent and descent to hypobaric condition
was maintained at 300 m/min. Fresh air was constantly ﬂushed in at a
rate of 8 L/min to prevent accumulation of CO2 within the chamber.
The temperature and humidity in the chamber were maintained at
28±2 °C and 55–60%, respectively. The animalswere randomly divided
into desired groups (as explained in the Results section) with 5 animals
in each group. The control groups were kept at normal atmospheric
pressure (Normoxic control) under similar conditions.
2.3. Administration of H2S Donor
The animals, in designated groups, received daily intra-peritoneal
(i.p.) injection of Sodium hydrogen sulﬁde (NaHS·xH2O, Cayman
Chemicals) at 4 mg per kg of body weight per day for 10 days prior to
HH exposure. NaHS (2 mg/mL) was prepared fresh in 0.15 M
phosphate-buffered saline (PBS) pH 7.4 before each injection. Parallel
sham injectionswith equal volume of 0.15MPBSweremade in the con-
trol groups.2.4. Morris Water Maze (MWM) Test
MWM test to assess spatial referencememorywas performed as per
published protocol (Vorhees and Williams, 2006) and described in de-
tail in the Supplemental Text.
2.5. T-Maze Test
For alternative test of cognition, ‘Rewarded Alternation Test’ was
performed employing T-Maze, as per published protocol (Deacon and
Rawlins, 2006) and described in Supplemental Text.
2.6. Intracellular Cleaved-Caspase 3 Staining, TUNEL, Flow Cytometry, In
Situ TUNEL, NOx and cGMP Estimation
These assays were performed utilizing commercially available kits
and standard protocols described in Supplemental Text.
2.7. Microarray Analysis
One-color microarray based gene expression analysis was per-
formed utilizing Agilent microarray platform and all raw data sets
were submitted to GEO (Accession number: GSE66287). Experimental
design, sampling, hybridization and data analysis were performed in
strict compliance with Minimum Information About a Microarray Ex-
periment (MIAME) guidelines. Data pre-processing and differential ex-
pression analysis was conducted by R software using Bioconductor
packages as reported previously (Sharma et al., 2014) and described
in Supplemental Text.
2.8. Bioinformatic Analysis
Gene Ontology (GO), Pathway Mining, and Functional Annotation
Clustering was done utilizing DAVID Bioinformatics resource (NIAID,
NIH). Gene MANIA (Warde-Farley et al., 2010) (as Cytoscape plug-in)
was used to extract functional networks representing non-redundant,
statistically signiﬁcant biological processes, depicted as degree sorted
circular view. This tool caters a unique advantage with the output net-
works from a query gene list principally based on well-established, ex-
perimentally inferred expression data sets from published studies. The
over- represented groups of GO and functional terms were established
utilizing software ‘BiNGO’ (as a Cytoscape plug-in).
2.9. Weighted Gene Co-Expression Network Analysis (WGCNA)
R packagewas used for executingWGCNA as described in (Langfelder
and Horvath, 2008) and brieﬂy described in Supplemental Text.
2.10. Transmission Electron Microscopy, Gelatin Zymography, Western
Blotting, Histological Analysis, Immunohistochemistry, Immunoﬂuorescence
These assayswere performed as per standard protocol and described
in Supplemental Text.
2.11. BBB Permeability (Sodium Fluorescein Extravasation Assay)
The assay was performed as per protocol described previously
(Phares et al., 2006).
2.12. Estimation of Sulﬁde Levels by Zinc Precipitation Assay
Total free sulﬁde estimation in tissue samples was done as per pub-
lished protocol (Ang et al., 2012) and described brieﬂy in Supplemental
Text.
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Studies
Cerebral blood ﬂow (CBF) was measured utilizing Laser Doppler
Flowmetry (LDF), as per published protocol (Sutherland et al., 2014)
and brieﬂy, described in Supplemental Text. It measures blood perfu-
sion across the region of interest by estimating total blood cell ﬂux
(RBCs) traversing this region in a speciﬁc duration of time. The total
blood cell ﬂux is expressed as Blood Perfusion Units (BPU)—arbitrary
units proportional to the product of mean velocity and number of
blood cells traversing this region. Whisker Stimulation method was
employed for assessing functional hyperemia responses, as per protocol
described in Supplemental Text.
2.14. Statistics
The datasets from independent experiments (N ≥ 3)were represent-
ed either as Mean ± SEM, Box-Whisker Plots (with Median Values) or
Dot Plots (with Mean ± SEM). The statistical signiﬁcance of individualFig. 1. Hypobaric Hypoxia induces spatial memory impairment concomitant with the loss of H
utilized forMorrisWaterMaze test. Training of the animals consisted of two days ofwater habitu
indicated duration of time. B) Line graph depicting Latency (Time taken (in seconds) to reach th
area). Mean ± S.D. is shown. D) Bar graph representing Latency and E) Path Length paramete
Latency and G) Path length parameters in MWM test with respect to the performance of same
alternation task in elevated T-Maze. I) Bar graph representing performance of animals in T-M
(10× & 20×) showing cleaved-Caspase 3-positive cells (Alexa ﬂuor 488, Green) from hippoca
also counterstained with DAPI (Blue) to indicate location of cells. DAPI staining pattern for
representing average number of active (Cleaved) Caspase 3-positive cells per microscopic ﬁe
from hippocampal region of animals kept in Normoxia or 7 days of HH. Flow Cytometry analy
hippocampal tissues of animals kept in Normoxia or 7 days of Hypobaric Hypoxia. Statistical s
of variance (*P b 0.05, ***P b 0.001). Bonferroni multiple comparison test was conducted as a
Hypobaric Hypoxia (HH) exposure).parameters within multiple groups of speciﬁc experiment was evaluat-
ed by one-way analysis of variance (*P b 0.05, **P b 0.01, ***P b 0.001).
At speciﬁc instances (as noted in ﬁgure legends), Bonferroni multiple
comparison test was conducted as a post-hoc analysis.
3. Results
3.1. Hypobaric Hypoxia (HH) Induces Spatial Memory Impairment Con-
comitant with the Loss of Hippocampal Neurons
We began by establishing the time window, during which HH-
induced signiﬁcant deﬁcit in spatial memory manifests in the ‘trained
animals’ (utilizing Morris Water Maze Test). The experimental strategy
for this test is schematically represented in Fig. 1A. As shown in Fig. 1B &
C, time taken by the animals (Latency) to reach the platform, and path
length covered to reach it, constantly decreased with each day during
the 5 days training regimen prior to exposure to hypobaric hypoxia. No-
tably; in stark contrast to the animals kept in Normoxic environment
subsequent to training, the exposure of animals to 7 days of Hypobaricippocampal neurons during HH A) Schematic representation of the experimental strategy
ation,ﬁve days of training followedby probe trial prior to HypobaricHypoxia exposure for
e platform), andC) Path Length (Distance (inm) travelled by the rat to ﬁrst hit the platform
rs in MWM tests (Mean ± S.D.). F) Box-and-whisker plot showing percentage change in
animal during probe trial. H) Line graph depicting time-dependent learning of rewarded
aze test, after indicated duration of exposure to HH. J) Immunoﬂuorescence micrographs
mpal region of brain from animals kept in Normoxia or 7 days of HH. The sections were
respective regions is shown below Caspase-3 panels (labeled in ﬁgure). K) Bar graph
ld (10×). L) Representative image of Western blotting (Caspase 3) in extracts prepared
sis: M) Intracellular cleaved-Caspase 3 staining N) TUNEL staining, in cells isolated from
igniﬁcance of speciﬁc parameters shown in the ﬁgure was evaluated by one-way analysis
post-hoc analysis. (Abbreviations: N: Normoxic control, H1, H3 & H7: 1, 3 & 7 days, post
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by increase in the average value of latency andpath length for this group
(Fig. 1D & E). To account for the intra-group variations in the responses
of individual animals, we also calculated the change in latency and path
length for individual animals, post hypoxia, in comparison to reference
values for the same animal during probe trial, PT (refer methods for de-
tails). As shown in the box-whisker plots in Fig. 1F & G, we observed a
signiﬁcant increase (p b 0.001) in the median value for latency and
path length in H7 group.
As an additional test of cognition and hippocampal function;we also
monitored the animals for rewarded alternation tasks, utilizing elevated
T-maze (Deacon and Rawlins, 2006), following Hypobaric Hypoxia ex-
posure. Fig. 1H shows the day-wise pattern of learning (mean % cor-
rect). The animals, with each day of training, progressively learnt to
perform the task, reaching a score ≥85% on the ﬁfth day (Fig. 1H). Sub-
sequently, the designated groups of animals were exposed toHypobaric
Hypoxia for 1, 3 and 7 days, respectively and tested for their ability to
recapitulate rewarded alternation task. As shown in Fig. 1I, 7 days of
Hypobaric Hypoxia signiﬁcantly impacted the performance of these
(trained) animals in executing this task and thus, corroborating the ef-
fect of extended Hypobaric Hypoxia exposure on cognitive function.
To study the effect of chronic hypoxia on viability of the brain cells,
we performed Caspase 3 staining and TUNEL assay. Fig. 1J shows repre-
sentative immunoﬂuorescence images for cleaved-Caspase 3 (active
form) staining in the hippocampal region (critical for memory and cog-
nition) of animals exposed to Normoxia or 7 days of HH.We observed a
signiﬁcant increase in the number of cleaved-Caspase 3-positive foci
(Fig. 1J & K) in this region. Interestingly, as evident from the images
shown in Fig. 1J, we observed relatively higher number of Caspase 3-
positive cells in hippocampal CA3 region—known to predominantly
contain pyramidal neuron bodies. To further support HH-induced Cas-
pase 3 activation in this region, we also performedwestern blotting uti-
lizing hippocampal tissue extracts (Fig. 1L) besides intracellular
cleaved-Caspase 3 staining (Flow Cytometry) in the cells isolated from
hippocampal region (Fig. 1M). Both these experiments independently
supported activation of Caspase 3 in the hippocampal cells, after
7 days of exposure to HH. Further, in situ TUNEL assay in cells (Flow Cy-
tometry) isolated from the hippocampal tissue (Fig. 1N) yielded direct
evidence for increased number of apoptotic cells in this region. In
view of apoptotic events in the region composed of pyramidal neurons,
it appears likely that HH affects the viability of pyramidal neurons in
hippocampal region.
3.2. Weighted Gene Coexpression Network Analysis Suggests HH-Induced
Early Vascular Dysfunction
To capture temporal dynamics of hypoxia responses in hippocam-
pus, we next generated global gene expression signatures after 1, 3
and 7 days of hypoxia exposure (Supplemental Tables 1, 2 & 3) and sub-
jected this data to multiple analysis strategies (depicted diagrammati-
cally in Fig. 2A). Interestingly, the principal component analysis (PCA)
(Fig. 2B), hierarchical clustering (Fig. 2C) and sample dendrogram inFig. 2.Weighted Gene Coexpression Network Analysis (WGCNA) of time series global expres
differentially expressed genes were subjected to various softwares including DAVID (Onli
Coexpression Network Analysis (WGCNA). The biological networks were then represented
B) Principal Component Analysis (PCA) of gene expression data sets from the hippocampus o
dimensional plot of PC1 (Component 1) and PC2 (Component 2). C) Hierarchical clusteri
individual genes. D) Clustering dendrogram of samples based on their Euclidean distance. T
E) Modules (represented with unique color) corresponding to branches of cluster tree genera
F)Dendrogramobtained by clustering ofmodule Eigengeneswith dissimilarity based on topolo
module with Eigengene value b0.1 represented by unique color. The original module color (as
trait association plot representing relationship of modules with Latency (Time taken to reach th
platform). Rows correspond tomodule Eigengenewhile columns to Latency and Path Length. R
groups of GO and functional terms identiﬁed from various modules using hyper geometric test
identiﬁed by boxes. J) The top panel shows the bar graph obtained by plottingmodule Eigengen
map of expression values of genes composing respective modules.correlation with traits value represented as trait heat map, (Fig. 2D)
clearly segregated day 1 data set from days 3 and 7. These observations
strongly suggested plausible unique nature of responses at day 1.
We, therefore, generated amatrixwith expression values of genes dif-
ferentially modulated across various time points (days 1, 3 & 7) and sub-
jected this array to an elegant statistical networking tool, Weighted Gene
Coexpression Network Analysis (WGCNA) (Langfelder and Horvath,
2008). This tool generated inter-genic interactions based on the correla-
tion between respective time-dependent expression patterns of various
genes and did not consider a priori biological information for network
construction. As shown in notable previous publications (Langfelder
and Horvath, 2008; Oldham et al., 2006, 2008), such analysis potentially
segregates cell-type speciﬁc and/or biological process-speciﬁc modules
having unique expression patterns across various time points. With our
data set, the initial weighted gene co-expression network construction
returned 9 modules, represented with unique color codes in Fig. 2E.
Fig. 2F illustrates the hierarchical clustering of different modules based
on their speciﬁc Eigengene value. We, subsequently, fused modules
with an Eigengene value b0.1 to obtain 6 modules signiﬁcantly different
from each other and represented these with a unique color code in
Fig. 2G. As noted above, the geneswithin speciﬁcmoduleswere expected
to have unique co-expression patterns andhence, likely to compose adis-
tinct biological entity (process/cell type). As an initial test for themodules
constructed in our analysis, we sought to establish module trait relation-
ship based on correlation betweenmodule Eigengene and speciﬁc spatial
memory traits (latency and path length) recorded in our experiments.
This analysis showed signiﬁcant correlation values (close to +1 &−1)
between pink and brown module with the two traits in question
(Fig. 2H). We then grossly ascribed a biological identity to individual
modules by superimposing Gene Ontology (GO) information on individ-
ualmodules. As evident from the perfuse forced directed clustering of GO
terms from various modules (shown in Fig. 2I); the two modules (pink
and brown), having highest correlation valueswith spatialmemory traits
(described above), contained sub-clusters of biological processes includ-
ing cognition, sensory perception, neuron development andmorphogen-
esis. This observation underscored the gross functional relevance of
modules constructed byWGCNA fromwithin our temporal gene expres-
sion data set.
Interestingly, the green module was principally composed of GO
terms related to cellular signaling regulating Vascular tone (Calcium
Ion homeostasis, cyclic nucleotides, GPCRs and Catecholamine metabo-
lism and smooth muscle contraction) while the blue module primarily
contained other broad key terms related to vasculature (Angiogenesis,
Smooth muscle proliferation and Junctional maintenance). Red and
black modules did not return GO terms, which clustered to compose
unique biological processes and hence, excluded from the current de-
scription. Taken together, WGCNA analysis segregated key biological
processes, and speciﬁc clusters of genes regulating them, from amongst
complex temporal expression patterns in hypoxic brain.
Themodule ‘Eigengene’ value represents a grossmeasure of module
perturbation at a speciﬁc stage (time point in our case). To understand
the temporal kinetics of various biological processes associated withsion data. A) Scheme of data mining employed for analyzing microarray data. The lists of
ne resource), BiNGO and GeneMANIA (as Cytoscape plugins) besides Weighted Gene
as ‘Degree sorted circular view’ and GO networks as ‘Perfused forced directed clusters’.
f animals exposed to HH (Days 1, 3 and 7) and Normoxia (Control) represented as two
ng of gene expression data. Color intensities correspond to log2 expression values of
he trait Heat Map is depicted for the Path Length and Latency parameter of MWM test.
ted from clustering dendrogram of genes with dissimilarity based on topological overlap.
gical overlap. Red line indicates cut-off value (0.1) G) Cluster dendrogram showingmerged
shown in panel E, utilized for dynamic tree cut) is also included for reference. H) Module-
e platform, in seconds) and Path Length (Distance (in m) travelled by the rat to reach the
espective correlation and p-values are indicated in each cell. I) Clustered, over-represented
in BiNGO (Cytoscape plug-in). The ﬁgure indicates gross annotation for GO term clusters
e value (y-axis) plotted against time (HH Days 1, 3 & 7). The bottompanel represents heat
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along with heat map of expression values of speciﬁc genes composing
thesemodules at all three time points (Fig. 2J). This data showed several
interesting observations. The green and bluemodules, whichwere prin-
cipally composed of GO terms related to vascular components and relat-
ed signaling processes, showed maximum perturbation at day 1 (Note
the Eigengene values and expression patterns of module genes shown
as heat maps). In stark contrast, pink and brown modules, which were
composed of terms related to neurons, showedmaximum perturbation
and expression of respective genes by day 7. Taken together, these ob-
servations revealed several facts and raised some interesting possibili-
ties: 1) Vascular dysfunction appeared to manifest early (at day 1) in
response to HH 2) It temporally preceded perturbation of neuronal pro-
cesses evident at day 7, post HH 3) Vascular dysfunction, an apparently
early event, could play a causal role in initiating the cascade culminating
in neuro-physiological perturbations (cognitive deﬁcit) in response to
HH.
3.3. Evidence for Involvement of Multiple Vasomodulatory Mediators dur-
ing HH-Induced Early Vascular Injury
To further validate temporal segregation of responses as inferred by
WGCNA analysis, we extracted gene networks enriched at individual
time-points utilizing a vividly reported biological network construction
tool, ‘Gene MANIA’ (Warde-Farley et al., 2010). Fig. 3 shows degree
sorted circular view of key networks (biological co-expression and co-
localization) representing non-redundant, statistically signiﬁcant bio-
logical processes at day 1 (post HH). In agreement with the GO term
clustering of Blue and Green Modules (having maximum perturbation
at day 1, Fig. 2J), this analysis also showed enrichment of biological net-
works regulating blood pressure, vessel size and development, Calcium
homeostasis, corticosteroid responses, Wound healing (including he-
mostasis/angiogenesis), Extracellular Matrix dynamics, Corticosteroid
responses, leukocyte migration/activation, Cell adhesion and morpho-
genesis at day 1. Notably, biological networks related to core neurolog-
ical processes such as regulation of behavior, Neuron projection, Nerve
Transmission, Dendritic spine showed up only in day 3 and 7 data sets
(Supplemental Figs. 1 & 2; Supplemental Tables 4& 5), corroborating in-
ferences drawn from WGCNA analysis. Taken together, these data sets
reinforced the possibility that HH induces vascular dysfunction and in-
jury with plausible sequelae of corticosteroid response, wound healing,
coagulation/hemostatic processes involving platelets/leukocyte activa-
tion and ECM dynamics during early responses (day 1).
In view of unique nature of responses at day 1 (Fig. 2) and likely,
causal role in cascade of events culminating in neuro-pathological effects
of hypoxia (Figs. 2 & 3);we performed several additional analyses on this
data set. Table 1 shows the canonical ‘KEGG’ and ‘Panther’ pathways ex-
tracted from the list of differentially expressed genes at day 1. As clearly
observed from this list, the top statistically signiﬁcant pathways included
Coagulation and hemostasis, Calcium homeostasis, Smooth muscle con-
traction, Steroid hormone synthesis and GPCR signaling pathways trans-
ducing signals from vascular tone modulators including Endothelin,
Angiotensin, Catecholamines (Epinephrine/Norepinephrine), Dopamine
and 5-HT. Besides this, the data was suggestive of involvement of differ-
ent classes of heterotrimeric G- proteins. Most of these pathways modu-
late Actomyosin organization and ‘Calcium Sensitivity’ in various cell
types, including vascular smooth muscle, endothelial and neurons. In
consequence, these pathways regulate diverse biological processes
such as vascular tone, axon guidance and cell migration amongst several
others. Notably, the data also suggested modulation of Gap junctions,
Focal adhesion, Integrin and TGF-β receptor signaling—known to be in-
volved in ECM dynamics, cell–cell communication, structural and func-
tional tissue integrity. It thus appeared reasonable that the resultant of
HH-inducedmultiple vasomodulatory cues converging on cellular ‘Calci-
um Sensitivity’ via GPCR pathways causally governed the onset of early
vascular injury. This injury, in likely consequence, modulated ECM-dynamics via multiple receptors and pathways involved in structural
maintenance of tissues.
3.4. Ultra-Structural and Histological Evidence for the Early ‘Glio-Vascular’
Unit Perturbation
The likely involvement of vascular injury and tissue remodeling
prompted us to investigate ultra-structural changes in rat brain after
days 1, 3 & 7, post HH exposure. Fig. 4A shows the Electron micrographs
of rat brain sections, post Hypobaric Hypoxia exposure. A careful analysis
of these images revealed two striking observations: First, there was evi-
dence for Astrocyte end feet swelling and second, the width of basement
membrane (BM), as measured in high resolution EM images, was signif-
icantly lower than that observed in Normoxic animal (Fig. 4B). These ob-
servations suggested perturbation of ‘Glio-Vascular’ organization under
hypoxic condition. As described in a logical order below, we additionally
studied various phenomena—which could either corroborate ormanifest
as a consequence of such Glio-Vascular dysfunction.
The Astrocyte end feet swelling could likely be suggestive of its
activation—marked by increase of GFAP expression in these cells. We
therefore performed immunoﬂuorescence and western blotting exper-
iments utilizing speciﬁc antibody against rat GFAP. A representative IF
staining is shown in Fig. 4C and mean expression from 3 independent
experiments (estimated by intensity thresholding method utilizing
Image J) in Fig. 4D. The western blotting result for GFAP expression is
shown in Fig. 4E. We reproducibly observed signiﬁcant increase in the
expression of GFAP in response to hypoxia, suggesting activation of As-
trocytes under these conditions.
Several previous studies (related to Stroke, Ischemic Brain Injury
amongst others) had shown that the increased activity of Serine
Proteases (Tissue Plasminogen Activator (tPA), Urokinase) and Matrix
Metalloproteinases (MMPs) is causally linked to degradation of
ECM proteins—critically required to maintain basement membrane
(BM) (Hermann and ElAli, 2012). We were thus prompted to study
MMP activities under various conditions, utilizing Gelatin- and Casein-
substrate zymography. The representative Gelatin zymography results,
utilizing brain extracts, are depicted in Fig. 4F. We observed a signiﬁcant
increase in the activity of MMP 9 in brain extracts from animals exposed
to 1 day of hypobaric hypoxia. This activity, however, decreased at the
subsequent time points analyzed. The activity of MMP 2 did not show
much change in response to HH. The speciﬁcity of matrix metallopro-
teinase activity was established by employing two inhibitors of MMPs,
o-Phenanthroline and EDTA (Fig. 4F). We could not detect any MMP 8
activity, either in normoxic or hypoxic samples, at any time point in
our casein zymography experiments. Taken together, these experiments
showed increase in MMP 9 activity during early hypoxia responses. The
increase in this activity did not appear to be regulated at the level of tran-
scription, as inferred from the lack of MMP 9 transcript within differen-
tially expressed genes at day 1, 3 or 7. Notably, however, the
expression of tPA (PLAT), known to promote MMP 9 activity, was in-
creased at all time points in our data set (Fig. 4G).
The erosion of basement membrane and activation of Astrocytes
could be causally linked to possible endothelial dysfunction/activation.
To investigate this possibility, we performed vWF staining—a marker
of endothelial activation. As evident from representative IHC images
depicted in Fig. 4H and average expression in each group in Fig. 4I, we
observed a time-dependent increase in vWF expression in hypoxic rat
brain. Notably, our transcriptome data also showed increase in tran-
script for vWF at all time points studied. Furthermore, increased expres-
sion of soluble ICAM-1 (sICAM-1) is also suggested to be a surrogate
‘plasmamarker’ of endothelial activation. To further support our obser-
vation of HH-induced endothelial activation, we performed western
blotting with plasma samples from animals exposed to HH. As shown
in Fig. 4J, we clearly observed increase in sICAM-1 in a time dependent
manner on exposure to HH. Taken together, these observations clearly
suggested an early endothelial dysfunction in response to HH.
Fig. 3. Enrichment of non-redundant biological processes related to vascular injury during early phases (Day 1) of HH. The list of differentially expressed genes (Hippocampus, day 1 post
HH) was subjected to analysis employing ‘GeneMANIA’ and the networks representing signiﬁcantly enriched biological processes were represented as ‘Degree sorted circular view’.
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Table 1
Panther and KEGG pathways (Day 1).
Panther Pathways
Term Count P Value Genes Fold change(Log2)
P00011:Blood 
coagulation 16 5.77E–04 SERPINE1 2.8443542
TFPI 1.7853713
F2RL2 1.7642052
PROCR 1.7160616
PLAT 1.6604576
VWF 1.4912715
PLAUR 1.453474
ITGA2B 0.8921404
THBD –0.7324126
F13A1 –0.9336469
SERPINF1 –1.0370221
GP1BA –1.2040944
MUG2 –1.3793478
F2 –1.446238
SERPIND1 –3.5333004
F5 –4.70774
P05912:Dopamine 
receptor mediated 
signaling pathway
19 0.002892104 PPP1R1B 2.3757234
DRD2 2.36874
GRAP 1.8972919
CLIC1 1.2507586
FLNB 0.9297929
EPB4.1 0.8747859
GNG11 0.8746779
EPB4.1L5 0.6921451
COMTD1 –0.7163787
HDC –0.7939477
TH –0.8683033
DBH –0.8810172
LOC689709 –0.9149811
DRD4 –1.4644895
DDC –2.2620616
TPH1 –2.763118
CLIC6 –3.125873
SLC18A2 –3.1415696
SLC6A3 –7.033893
P00019:Endothelin 
signaling pathway 21 0.003854266 NOS3 1.6831317
ADCY5 1.2960057
PIK3CD 1.271533
ADCY4 1.1854753
PLCB1 1.1200645
RET 1.100955
ADCY10 0.9667928
PLA2G4E 0.93243885
PKN3 0.88681936
PRKCB 0.8609204
ITPR1 0.8332429
AKT2 0.7436042
RPS6KA5 0.7115321
PIK3R1 0.6818552
ECEL1 0.6579509
PRKCA –0.7844
PRKCG –0.7435055
NOS2 –0.7568853
EDNRB –0.7804198
EDN1 –0.9989674
GNA14 –1.1019769
P00026:Heterotrim
eric G–protein 
signaling pathway–
Gi alpha and Gs 
alpha mediated 
pathway
28 0.021559023 ADORA2A 4.596356
RGS9 3.3028097
HTR1D 2.4813447
DRD2 2.36874
RGS18 2.0005836
GNG7 1.457036
ADCY5 1.2960057
ADCY4 1.1854753
RET 1.100955
PYGL 0.98676443
GYS2 0.951998
ADRA2C 0.9169922
GNG11 0.8746779
HRH3 0.84554243
HTR2A 0.8191047
RGS11 0.7829354
GNAL 0.7655735
CREM 0.74777603
ADRB2 0.67456627
HTR5B –0.68358994
KCNJ9 –0.70458364
HTR2C –0.71320677
HTR7 –0.8106084
ADRB3 –0.85165596
HTR2B –0.97994566
GNRHR –1.1969903
LOC685513 –1.2585919
DRD4 –1.4644895
P00014:Cholesterol 
biosynthesis 6 0.034031065 HMGCS2 0.6745615
RGD156159
4 –0.6385875
RGD156020
8 –0.66789436
HMGCS1 –0.712842
FDPS –0.7152734
IDI1 –0.8051386
MVD –1.1668863
P05911:Angiotensi
n I–stimulated I
signaling through G 
proteins and beta–
arrestin
11 0.05914163 GNG7 1.457036
PLCB1 1.1200645
GNG11 0.8746779
PRKCB 0.8609204
ITPR1 0.8332429
PRKCG –0.7435055
PRKCA –0.7844
RHOD –1.0399897
RSA–14–44 –1.2486258
LOC685513 –1.2585919
AGTR1A –1.5141063
P00034:Integrin 
signalling pathway 33 0.060880193 GRAP 1.8972919
FN1 1.8335872
ABL1 1.6461685
COL4A1 1.5585132
COL17A1 1.5140443
COL4A2 1.4545646
ITGA5 1.3283875
PIK3CD 1.271533
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P04371:5–
Hydroxytryptamine 
biosynthesis
4 0.021548497 HDC –0.7939477
TH –0.8683033
DDC –2.2620616
TPH1 –2.763118
ARPC1B 1.1639299
FLNB 0.9297929
ITGA2B 0.8921404
LOC683963 0.8268299
LOC367516 0.8187952
ACTN1 0.7967496
COL13A1 0.7933414
LAMC2 0.7582145
COL7A1 0.7147064
CAV1 0.7034116
LOC685488 0.70186234
LAMA5 0.69947433
PIK3R1 0.6818552
LOC679711 0.67974806
LAMC1 0.60901594
ITGB2 –0.6738734
COL11A2 –0.69414854
COL9A1 –0.6942651
COL5A2 –0.7076521
LIMS1 –0.75985765
COL14A1 –0.7926967
LOC363337 –0.9194498
COL10A1 –1.0163882
RHOD –1.0399897
COL3A1 –1.1294589
RSA–14–44 –1.2486258
COL8A1 –1.3336091
COL1A2 –1.4690781
ITGB6 –1.8243966
P00001:Adrenaline 
and noradrenaline 
biosynthesis
8 0.078337129 COMTD1 –0.7163787
HDC –0.7939477
TH –0.8683033
DBH –0.8810172
DDC –2.2620616
TPH1 –2.763118
SLC18A2 –3.1415696
SLC6A3 –7.033893
P00027:Heterotrim
eric G–protein 
signaling pathway–
Gq alpha and Go 
alpha mediated 
pathway
22 0.096524454 ADORA2A 4.596356
RGS9 3.3028097
RASGRP2 3.1607108
DRD2 2.36874
RGS18 2.0005836
GNG7 1.457036
PLCB1 1.1200645
GNG11 0.8746779
PRKCB 0.8609204
ITPR1 0.8332429
RGS11 0.7829354
RAP1GAP 0.7810283
ARHGEF11 0.7358856
CACNA1A –0.61188555
KCNJ9 –0.70458364
PRKCG –0.7435055
PRKCA –0.7844
RHOD –1.0399897
GNRHR –1.1969903
RSA–14–44 –1.2486258
LOC685513 –1.2585919
DRD4 –1.4644895
ITGA2B 0.8921404
LAMC2 0.7582145
LAMA5 0.69947433
LAMC1 0.60901594
LOC681309 –0.6848483
COL11A2 –0.69414854
COL5A2 –0.7076521
CHAD –0.73622775
COMP –1.0570307
COL3A1 –1.1294589
THBS2 –1.2029161
GP1BA –1.2040944
COL1A2 –1.4690781
ITGB6 –1.8243966
SPP1 –2.052303
rno04510:Focal 
adhesion 39 1.13E–04 VEGFA 2.246623
FLT1 2.0796452
KDR 2.040841
SHC4 1.966058
FN1 1.8335872
COL4A1 1.5585132
VWF 1.4912715
COL4A2 1.4545646
ITGA5 1.3283875
PIK3CD 1.271533
IBSP 1.1771476
FLNB 0.9297929
ITGA2B 0.8921404
PRKCB 0.8609204
LOC501280 0.8587365
ACTN1 0.7967496
BIRC3 0.77315354
LAMC2 0.7582145
AKT2 0.7436042
VEGFC 0.7373686
CAV1 0.7034116
LAMA5 0.69947433
CTNNB1 0.6886425
PIK3R1 0.6818552
LAMC1 0.60901594
LOC681309 –0.6848483
COL11A2 –0.69414854
COL5A2 –0.7076521
CHAD –0.73622775
PRKCG –0.7435055
CAV3 –0.74353504
PRKCA –0.7844
COMP –1.0570307
COL3A1 –1.1294589
THBS2 –1.2029161
RSA–14–44 –1.2486258
COL1A2 –1.4690781
ITGB6 –1.8243966
SPP1 –2.052303
rno04540:Gap 
junction 20 5.86E–04 DRD2 2.36874
TUBB6 1.5840988
ADCY5 1.2960057
ADCY4 1.1854753
GUCY1B3 1.1435361
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KEGG Pathways 
rno04512:ECM–
receptor interaction 22 6.63E–05 FN1 1.8335872
COL4A1 1.5585132
VWF 1.4912715
COL4A2 1.4545646
ITGA5 1.3283875
IBSP 1.1771476
CD36 1.1001186
PLCB1 1.1200645
GUCY1A3 0.8903427
PRKCB 0.8609204
ITPR1 0.8332429
HTR2A 0.8191047
TUBA4A –0.6209159
TUBA1B –0.657351
HTR2C –0.71320677
PRKCG –0.7435055
TUBB5 –0.75383997
TUBB3 –0.76714754
PRKCA –0.7844
TUBA1C –0.8032026
TUBA8 –0.96178055
HTR2B –0.97994566
rno00100:Steroid 
biosynthesis 8 0.001061499 HSD17B7 –0.6217203
NSDHL –0.7051382
SQLE –0.7577033
CYP51 –0.83079195
DHCR24 –0.84135437
TM7SF2 –0.95091915
DHCR7 –0.96000814
SOAT2 –2.136528
rno04514:Cell 
adhesion molecules 
(CAMs)
28 0.002969832 PECAM1 2.4711046
ESAM 1.5237026
RT1–N3 1.5197141
SELE 1.2301354
PVR 1.0194507
CLDN5 1.0137239
RT1–N1 1.0022795
CLDN11 0.9885502
MPZL1 0.9415822
F11R 0.81968594
NFASC 0.7557125
PTPRM 0.7454734
PTPRC –0.66197205
ITGB2 –0.6738734
CD34 –0.6803694
NRXN2 –0.7213731
CLDN1 –0.7981963
MPZ –0.9497359
RT1–T18 –0.9589927
RT1–DB1 –1.0709939
VCAN –1.0723538
RT1–DA –1.2743809
CDH1 –1.6283634
CLDN3 –1.6335094
RT1–BB –1.8330176
CDH3 –2.8483317
GLYCAM1 –5.4058876
CLDN2 –5.5740385
rno04614:Renin–
angiotensin system 8 0.003190858 MME 1.4994779
ENPEP 1.268023
MAS1 –0.63812685
ACE –0.67749214
CPA3 –1.2984309
MCPT10 –1.3249769
AGTR1A –1.5141063
CMA1 –1.5416882
PRKCA –0.7844
CLDN1 –0.7981963
RSA–14–44 –1.2486258
TXK –1.5115731
CLDN3 –1.6335094
CLDN2 –5.5740385
rno04020:Calcium 
signaling pathway 32 0.004521905 ADORA2A 4.596356
NOS3 1.6831317
ADCY4 1.1854753
PLCB1 1.1200645
PDE1B 1.0738964
PRKCB 0.8609204
P2RX4 0.84352183
ITPR1 0.8332429
HTR2A 0.8191047
GNAL 0.7655735
ADRB2 0.67456627
CAMK4 0.6577492
CACNA1A –0.61188555
HTR5B –0.68358994
ATP2A1 –0.6867933
HTR2C –0.71320677
SLC8A1 –0.7239742
P2RX2 –0.73717046
PRKCG –0.7435055
NOS2 –0.7568853
PLN –0.7792568
EDNRB –0.7804198
PRKCA –0.7844
HTR7 –0.8106084
ADRB3 –0.85165596
RYR1 –0.924412
HTR2B –0.97994566
GNA14 –1.1019769
ATP2A3 –1.125823
NTSR1 –1.1850097
AGTR1A –1.5141063
CD38 –1.5396469
rno05222:Small cell 
lung cancer 17 0.011903225 FN1 1.8335872
COL4A1 1.5585132
COL4A2 1.4545646
PIK3CD 1.271533
MAX 0.91229844
ITGA2B 0.8921404
RARB 0.8681197
BIRC3 0.77315354
LOC687813 0.7597294
LAMC2 0.7582145
AKT2 0.7436042
LAMA5 0.69947433
PIK3R1 0.6818552
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rno04670:Leukocyte 
transendothelial 
migration
23 0.003879689 PECAM1 2.4711046
ITK 2.339603
ESAM 1.5237026
PIK3CD 1.271533
CLDN5 1.0137239
RAPGEF4 0.9965453
CLDN11 0.9885502
PRKCB 0.8609204
LOC501280 0.8587365
F11R 0.81968594
ACTN1 0.7967496
CTNNA1 0.7173381
CTNNB1 0.6886425
PIK3R1 0.6818552
NOX1 0.67736244
ITGB2 –0.6738734
PRKCG –0.7435055
RXRG 0.6225977
LAMC1 0.60901594
NOS2 –0.7568853
PDE11A –0.839766
rno04270:Vascular 
smooth muscle 
contraction
20 0.026360446 ADORA2A 4.596356
ADCY5 1.2960057
ADCY4 1.1854753
GUCY1B3 1.1435361
PLCB1 1.1200645
PLA2G4E 0.93243885
GUCY1A3 0.8903427
PRKCB 0.8609204
ITPR1 0.8332429
ARHGEF11 0.7358856
RAMP1 0.6719227
PRKCG –0.7435055
KCNMB2 –0.76567173
PRKCA –0.7844
ACTG2 –0.865891
CYP4A1 –0.95697904
PLA2G5 –0.96909213
RSA–14–44 –1.2486258
AGTR1A –1.5141063
CALCRL –1.6512504
rno04610:Complement 
and coagulation 
cascades
14 0.029442743 SERPINE1 2.8443542
TFPI 1.7853713
PLAT 1.6604576
VWF 1.4912715
PLAUR 1.453474
C8G –0.6398494
SERPINA5 –0.6831827
THBD –0.7324126
F13A1 –0.9336469
C3 –0.9861479
F2 –1.446238
C9 –1.7074528
SERPIND1 –3.5333004
F5 –4.70774
rno04062:Chemokine 
signaling pathway 27 0.034519164 RASGRP2 3.1607108
ITK 2.339603
SHC4 1.966058
GNG7 1.457036
ADCY5 1.2960057
PIK3CD 1.271533
ADCY4 1.1854753
PLCB1 1.1200645
CCL6 1.1072657
IQUB 0.8870621
GNG11 0.8746779
PRKCB 0.8609204
PF4 0.79803133
AKT2 0.7436042
PIK3R1 0.6818552
CXCL1 –0.6154723
CCL2 –0.74478173
CXCL9 –0.7801604
CCL25 –1.196212
RSA–14–44 –1.2486258
LOC685513 –1.2585919
HTR7 –0.8106084
GABRB3 –0.81573105
ADRB3 –0.85165596
HCRTR1 –0.86431456
LPAR2 –0.87759614
ADCYAP1R1 –0.8814521
GALR1 –0.9610293
HTR2B –0.97994566
TAAR7B –1.090653
NTSR1 –1.1850097
GNRHR –1.1969903
MCPT10 –1.3249769
F2 –1.446238
DRD4 –1.4644895
AGTR1A –1.5141063
PTGDRL –1.6005907
CALCRL –1.6512504
UTS2R –2.1746721
CALCR –2.7912755
PRLR –2.7981958
rno00900:Terpenoid 
backbone biosynthesis 5 0.05205725 HMGCS2 0.6745615
RGD1561594 –0.6385875
HMGCS1 –0.712842
FDPS –0.7152734
IDI1 –0.8051386
MVD –1.1668863
rno04350:TGF–beta 
signaling pathway 15 0.065006583 ACVR1 1.245075
LTBP1 1.0403204
NOG 0.8657832
ACVR1C 0.6979971
ZFYVE9 0.6862364
FST 0.65952444
SMAD9 –0.6656542
LOC681309 –0.6848483
BMP4 –0.7922139
DCN –0.81510496
BMP7 –0.9723568
COMP –1.0570307
THBS2 –1.2029161
RSA–14–44 –1.2486258
PITX2 –2.1505985
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CCL7 –1.4378674
CXCL11 –1.544837
CCL12 –1.5502553
CCL4 –1.5722265
CCL1 –1.5840888
XCL1 –1.8675163
rno04080:Neuroactive 
ligand–receptor 
interaction
38 0.038080904 ADORA2A 4.596356
HTR1D 2.4813447
DRD2 2.36874
F2RL1 1.9597049
F2RL2 1.7642052
ADRA2C 0.9169922
GABBR1 0.87944365
NMUR1 0.85039854
HRH3 0.84554243
P2RX4 0.84352183
HTR2A 0.8191047
GLRB 0.76673746
ADRB2 0.67456627
MAS1 –0.63812685
HTR5B –0.68358994
HTR2C –0.71320677
P2RX2 –0.73717046
EDNRB –0.7804198
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estingly, these experiments revealed relative increase in CD31-positive
regions in response to hypoxia—an observation consistent with report-
ed angiogenic propensity induced by hypoxia. Notably, this data is in
keeping with our transcriptome results, which also suggested modula-
tion of angiogenesis-speciﬁc networks at all time points studied.
Endothelial dysfunction, erosion of basementmembrane and activa-
tion of Astrocytes cumulatively suggested perturbation of Glio-Vascular
organization—a basic structural unit in brain critically regulating ‘BBB
function’. To investigate this further, we generated evidence utilizing
three independent experimental strategies—aimed at studying struc-
tural integrity and functional aspects of BBB. We ﬁrst performed co-
immunoﬂuorescence confocal microscopywith Laminin and Aquaporin
4 (Aqp 4). While Laminin stains basement membrane (BM), Aquaporin
4 stains the Astrocyte end feet. Under normal physiological conditions,
Aqp 4 positive Astrocyte end feet stay tightly and intimately clasped
to basal lamina via interaction with Agrin. However, any neuro-
pathophysiological condition of brain culminating in BBB dysfunction
is marked by disruption of this interaction and hence, perturbation of
this critical ‘Glio-Vascular’ structure. This phenomenon is evident as
segregation of Laminin and Aqp 4 signals in confocal images. As
shown in Fig. 4M and Pearson's correlation between spatial localization
of signals from the two ﬂuorophores [representing Aqp 4 and Laminin]
in Fig. 4N, we reproducibly observed a distinct segregation of Laminin
and Aqp 4 signals in response to 3 days of Hypobaric Hypoxia exposure.
This interaction was evidently restored by day 7 of HH exposure sug-
gesting that the propensity for functional loss of BBB was transient,
which peaked by day 3 and possibly restored by day 7 of HH response.
The loss of ‘BBB function’ implies that higher molecular weight pro-
teins including Albumin and Immunoglobulinswould cross BBB and ac-
cumulate in brain parenchyma. To investigate the same, we performed
two different experiments namely, Fluorescein extravasation assay
(Fig. 4O) and co-immunoﬂuorescence microscopy to monitor extravas-
cular IgG (in parenchyma) as a function of time (post HH), utilizing anti-
CD31 and -IgG antibodies (Fig. 4P). We observed a signiﬁcant increase
in the ﬂuorescein signal from hypoxic rat brain extracts (Fig. 4O) be-
sides clear increase in extravascular IgG (parenchyma) in rat brain sec-
tions at day 3 (Fig. 4P). Interestingly, similar to Laminin–Aquaporin 4
co-localization, we observed a relative reversal of these phenomenaby day 7 of HH exposure. Taken together, thus, our data strongly sug-
gested perturbation of BBB function (day 3) following an early brain
vascular dysfunction in response to HH.
3.5. Hypobaric Hypoxia Decreases H2S Levels in Brain and Impedes ‘Cue-
Dependent’ Changes in Cerebral Blood Flow
The decrease in Oxygen concentration in circulation leads to vaso-
constriction in pulmonary and systemic circulation but vasodilation in
cerebral vasculature through mechanisms grossly termed as ‘hypoxic
cerebral autoregulation’. Besides functional dependence on intact Glio-
Vascular integrity, an elevated production of H2S during hypoxic condi-
tions regulates vasodilation in brain (autoregulation) via inverse rela-
tionship between the activity of enzymes, Cystathionine beta synthase
(CBS, involved in H2S production) and Heme Oxygenase-2 (HO-2, in-
volved in CO production) (Morikawa et al., 2012). Thus, in view of
early vaso-modulatory signaling, Glio- vascular perturbation in re-
sponse to HH (as described in the previous sections) and the central
role of H2S in regulating hypoxic-autoregulation in brain; we sought
to measure H2S levels in rat brain, after 1 day of HH exposure. Interest-
ingly, as shown in Fig. 5A, we reproducibly observed signiﬁcant
decrease in the levels of H2S in response to 1 day of exposure toHH, rais-
ing the possibility of perturbed cerebral autoregulation and H2S
production during HH-induced responses in brain. H2S exerts its
vasodilatory effects through multiple pathways including inhibition of
Phosphodiesterase (PDE) activity and increasing Nitric Oxide synthase
activity (NOS), which cumulatively increases the levels of cGMP in
smooth muscle cells. We, therefore, additionally measured the levels
of Nitric Oxide (NO) and cGMP in hypoxic brain tissue after 1 day of ex-
posure to HH. As shown in Fig. 5B & C, we clearly observed signiﬁcantly
lower levels of NO and cGMP in the brain tissues of animals exposed to
HH. Taken together, we inferred that HH lowers H2S levels and as a like-
ly consequence, modulated the level of cGMP. We also exogenously ad-
ministered a known H2S donor, NaHS, to the animals, prior to HH
exposure. As also shown in Fig. 5A, pretreatmentwith NaHSmaintained
the levels of H2S in rat brain during HH. We additionally tested if the
levels of NO and cGMPwere also maintained during this condition. No-
tably, as clearly shown in Fig. 5B & C, NaHS pretreatment culminated in
signiﬁcant increase in the levels of NO and cGMP in the brain during HH
(1 day). These results cumulatively raised the possibility that HH-
induced down-regulation of H2S production could modulate ‘hypoxic
cerebral autoregulation’ – likely through involvement of cGMP.
To study the phenomenon (described above) at functional level, we
next sought to investigate the relative changes in CBF after 24 h of expo-
sure to hypobaric hypoxia, in animals with or without NaHS pretreat-
ment, employing Laser Doppler Flowmetry (LDF). As shown in Fig. 5D
& E, we observed a moderate, but statistically signiﬁcant, increase in
BPU value from animals exposed to 24 h (1 day) of HH (Mean BPU
values: 332 in Normoxia & 478 in HH). In striking contrast, animals re-
ceiving NaHS (kept in Normoxia or Hypoxia) showed amarked increase
in blood perfusion across similar region, as compared to Normoxic or
Hypoxic animals without NaHS administration (Mean BPU values: 857
& 1042, respectively), (Fig. 5D & E). Consistent with the possibility
raised by observations described in Fig. 5A–C, this data set yielded func-
tional evidence for the role of H2S in regulating vasodilation and effec-
tive increase in CBF—an adaptive advantage under hypoxic conditions.
In view of ‘cellular ﬂux-dependence’ of the LDF data (BPU), it was
likely to be affected by changes in the effective concentration (and
thus relative number) of bloods cells traversing a region of measure-
ment. Therefore, systemic increase in concentration of RBCs due to He-
matopoiesis/Erythropoiesis or Hemoconcentration was also likely to
produce changes in BPU values. Notably, both these phenomena are of
relevance under hypoxic settings, though with markedly different
time kinetics post HH. While Erythropoiesis sets in signiﬁcantly
late—only to be detected after several days of exposure to HH,
Hemoconcentration can be observed as early as 6 h post HH (likely
Fig. 4. Ultra-structural and histological evidence for the early ‘Glio-Vascular’ Unit perturbation A) Transmission electron micrographs of hippocampal sections, post HH exposure (1, 3 &
7 days) (Abbreviations: A: Astrocytes, B: Basementmembrane, E: Endothelial cells). Scale bar is 2 μm(I) and 1 μm(II) B) Bar graph showing Basementmembranewidth (in nm)measured
in the electronmicrographs of hippocampal regions after HH exposure (Mean±S.D.was plotted to obtain the graph). C) Immunoﬂuorescencemicrographs forGFAP staining, obtained for
hippocampal sections using confocal microscopy. Scale bar is shown in each image D) Mean Intensity (indicating GFAP expression), as estimated by Intensity thresholding method and
Image J software. E) Western blots showing GFAP expression in the hippocampal region of brain on exposure to HH for 1, 3 & 7 days. The GFAP signal was normalized to β-Actin and
average fold change in expression, w.r.t Normoxic is shown as bar graph. F) Representative gelatin zymograms indicating proteolytic activity of MMP-2 (72 kDa) and MMP-9 (92 kDa)
at 1, 3 and 7 days post-HH exposure (H1, H3 & H7) in the hippocampus. o-Phenanthroline (zinc-speciﬁc chelator) and EDTA (divalent metal ion-chelator) were also included in these
experiments to ensure speciﬁcity of MMP activity. G) Fold change (Log2) in the expression values (with respect to normoxic control) of tPA transcript at Days 1, 3 & 7, post HH.
H) Representative bright ﬁeld micrographs of Immunohistochemistry staining for vWF in sections from hippocampus, post HH exposure (obtained at 20× magniﬁcation). I) Average
expression of vWF, as estimated by intensity thresholding method, utilizing Image J software J) Representative western blots for sICAM-1 expression in plasma samples from animals
exposed to HH for the indicated period (H1, H3 & H7). The sICAM-1 expression signals were normalized to α-Tubulin, used as internal control and average fold change w.r.t Normoxia
shown as bar graph. K) Representative bright ﬁeld micrographs of Immunohistochemistry staining for CD31 in sections from hippocampus, post HH exposure (20× magniﬁcation).
L) Average expression of CD31, as estimated by intensity thresholding method, utilizing Image J software M) Co-immunoﬂuorescence confocal micrographs of AQP4 (Green) and
Laminin (Red) in the hippocampal sections from Normoxic and HH exposed animals (Days 3 & 7) at 20× magniﬁcation. Higher magniﬁcation regions from merged images are also
shown. Scale bar is included in the images. N) Bar graph representing Pearson's correlation for spatial co- localization of Green (AQP4) and Red (Laminin) channel signals in confocal
images O) Fluorescein Extravasation Assay to determine Blood Brain Barrier function. P) Immunoﬂuorescence micrographs from the hippocampal region stained for CD31 (Green) and
IgG (Red) under Normoxic as well as HH exposed condition (Days 3 & 7) at 20× magniﬁcation. (Abbreviations: N: Normoxic control, H1, H3 & H7: 1, 3 & 7 days, post Hypobaric
Hypoxia (HH) exposure).
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under hypoxic conditions). It was thus imperative to infer the LDF re-
sults (BPU) in conjunction with the relative changes in effective RBC
concentrations for all groups. We, therefore, additionally recorded
blood cell count in all four groups after 1 day of HH exposure and pre-
sented it in Fig. 5F. As expected, we observed nearly 1.2 fold increase
in hematocrit values in the animals exposed to hypoxia (irrespective
of NaHS treatment) (Fig. 5F). In view of these results, it appears likely
that themoderate increase in BPU value of hypoxic animals (not receiv-
ingNaHS) is a likely consequence of increased RBC number, as a result of
Hemoconcentration. In striking contrast, however, the pronounced in-
crease in BPU value of Normoxic animals receiving NaHS clearly sug-
gests it to be a consequence of vasodilation in brain vasculature (Note
that the hematocrit value of this group is comparable to Normoxiccontrols in these animals, Fig. 5F). Interestingly, the animals exposed
to hypoxia, along with NaHS administration, consistently showed
highest BPU values and thus, suggesting possible cumulative effects
from hemoconcentration and vasodilation under these conditions.
The results till this stage clearly suggested perturbation of Glio-
Vascular homeostasis and function by HH exposure and likely restora-
tion by H2S augmentation.We, therefore, additionally studied function-
al hyperemia responses—a measure of Neurovascular coupling—under
all four conditions (N, H, ND, HD). For the same, we utilized ‘Whisker-
Stimulation’ protocol (Lecrux et al., 2011) and recorded the changes in
CBF (in barrel cortex area) after rhythmic whisker stimulation.We rep-
resented the changes in CBF as ΔBPU—the difference in BPU values be-
fore and after whisker stimulation. As clearly shown by Fig. 5G & H, we
observed a signiﬁcant reduction in functional hyperemia (average CBF
184 G. Kumar et al. / EBioMedicine 6 (2016) 171–189
Fig. 6. Augmentation of endogenous H2S levels ameliorates Hypobaric Hypoxia induced early gliovascular perturbation A) Representative western blots of sICAM-1 expression in the
plasma samples obtained from the indicated groups: Normoxic (N), Normoxic with NaHS pretreatment (ND), Hypoxia (1 day) (H1) & Hypoxia (1 day) pretreated with NaHS (H1D).
The protein expression signals were normalized to α-Tubulin (loading control) and average fold change w.r.t Normoxic controls represented as bar graph (Mean ± S.D).
B) Immunoﬂuorescence micrographs of GFAP expression in hippocampal sections using confocal microscopy (at 20× objective) for indicated groups: Normoxia & Hypobaric Hypoxia
(HH) with/without NaHS pretreatment. Hypobaric Hypoxia (HH) exposure was done for 1 day in these experiments. The micrographs were estimated using Image J and data
presented as bar graph in ﬁgure C) Co-Immunoﬂuorescence confocal micrographs of AQP4 (green) and Laminin (red) in the hippocampal sections at 20× magniﬁcation. The groups
are indicated in the ﬁgure. Animals in hypoxic groups were exposed to 3 days of HH. D) Bar graph representing Pearson's correlation for spatial co-localization of Green (AQP4) and
Red (Laminin) channel signals in confocal images E) Fluorescein Extravasation Assay to determine Blood Brain Barrier function in animals exposed to 3 days of HH, with or without
NaHS pretreatment. F) Bar graph representing the Latency parameter (Time taken to reach the platform, in seconds) in MWM test (Mean ± S.D.) for various experimental groups.
Animals were kept in Normoxia (N, ND) or exposed to 7 days of HH, with (H7D) or without NaHS (H7) pretreatment. G) Bar graph representing the Path Length parameter (Distance
(in m) travelled by the rat to reach the platform) in MWM test (Mean ± S.D.) for said experimental groups (N, ND, H7, H7D). H) Box-and-whisker plot indicating percentage fold
change (Mean ± S.D.) in the Latency parameter of the indicated groups during the test w.r.t performance of the same animal in Probe Trial (PT). I) Box-and-whisker plot indicating
percentage fold change (Mean ± S.D.) in the Path Length parameter of the indicated groups during the test w.r.t performance of the same animal in Probe Trial (PT). J) Bar graph
representing performance of animals in T-Maze test, after 7 days of exposure to HH, with or without NaHS pretreatment. K) Representative regions from bright ﬁeld micrograph
showing cleaved-Caspase 3-positive foci (Immunohistochemistry) from brain sections of animals kept in Normoxia or 7 days of HH, with or without NaHS pretreatment. L) Flow
Cytometry analysis of cleaved-Caspase 3 (Alexa ﬂuor 488) positive cells from hippocampal tissues of animals kept in Normoxia or 7 days of HH, with or without NaHS pretreatment.
M) Flow Cytometry analysis of TUNEL (FITC) positive cells from hippocampal tissues of animals kept in Normoxia or 7 days of HH, with or without NaHS pretreatment. The
signiﬁcance of differences was evaluated by one-way analysis of variance (***P b 0.001). Bonferroni multiple comparison test was conducted as a post-hoc analysis.
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pared to Normoxic controls. Notably, this response was restored when
the animals were pretreated with NaHS (H2S augmented conditions)Fig. 5.HH-induced perturbation of vasomodulatory gaseous transmitters (H2S, NO), cGMP and
sulﬁde concentration B) NOx (Nitrate & Nitrite) concentration C) cGMP concentration in the
NaHS), Normoxia Drug (pretreated with NaHS). Animals were exposed to Hypobaric Hypoxia
of H2S, NOx and cGMP. The results are represented as Mean ± S.D. (* P b 0.05, **P b 0.01). D
ﬂow (CBF)) from Normoxic or Hypoxic animals, with or without H2S pretreatment. E) Scatter
group (Normoxic, Hypoxic, Hypoxia + NaHS or NaHS alone (Normoxia + NaHS). Median valu
(Hb) for animals from indicated groups. Respective units are also mentioned below the ﬁgur
The average change in CBF (ΔBPU) was calculated and represented as bar graph (Mean ± S.D
and after whisker stimulation in individual groups (Normoxia, Hypoxia, Hypoxia + NaHS, No
evaluated by one-way analysis of variance (*P b 0.05, **P b 0.01).prior to HH-exposure (Fig. 5G & H). These results, taken together, sug-
gested a likely critical role of H2S in regulating Neuro-Vascular coupling
besides Glio-Vascular homeostasis and function.H2S regulated changes in Cerebral Blood Flow (CBF) in brain. Bar graphs showing A) total
brain samples from various groups: Normoxia, Hypoxia, Hypoxia Drug (pretreated with
for 1 day. The standard curve in each assay was prepared utilizing known concentrations
) Overlay of signals obtained from Laser Doppler Flowmetry (indicating cerebral blood
plots of mean blood perfusion units (CBF) values from 6 individual animals within each
es are also indicated. F) Average values of RBC count, Hematocrit (Hct) and Hemoglobin
e. G) Functional hyperemia responses, studied employing Whisker Stimulation Protocol.
). H) Representative overlays of signals obtained from Laser Doppler Flowmetry, before
rmoxia + NaHS). Statistical signiﬁcance of various parameters shown in the ﬁgure was
Fig. 7. Proposed integrative working model. The scheme of events deciphered from current study have been schematically represented within a known framework of basic units of
function in brain, Neurovascular Units (NVU)—centrally regulating neurophysiological functions and Gliovascular Units—regulating BBB function besides cerebral blood ﬂow (CBF). The
brain oxygen sensing mechanism regulates cerebral autoregulation and CBF—likely through steady state levels of H2S in brain. The absence of sufﬁcient H2S levels under chronic
hypoxic conditions culminates in vascular dysfunction, involving endothelial and blood cell activation (regulating pathways such as hemostasis, inﬂammatory propensity and vascular
tone). These events culminate in increased proteolytic stress (involving proteases such as tPA, MMP9), basement membrane erosion, Astrocyte activation and loss of structural/
functional integrity of Gliovascular units. This likely increases the permeability of molecules such as glutamate (present at much higher concentrations in circulation than in brain) and
thus, culminating in neuronal damage concomitant with neuro-pathophysiological effects such as cognitive impairment.
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physiological Effects
We next sought to investigate if HH-induced decrease in the level of
H2S was causally linked to neuro-pathophysiological responses ob-
served during these conditions. For the same,we re-investigated a num-
ber of parameters in the animals, pretreated with NaHS to maintain
steady state levels of H2S during HH exposure. For investigating HH-
induced Endothelial dysfunction, we performed western blotting for
sICAM-1 in plasma samples from animals exposed to HH, with/without
NaHS pretreatment. As shown in Fig. 6A, we observed signiﬁcantly
lower levels of sICAM in HH-exposed animals, pretreated with NaHS.
This observation clearly suggested efﬁcacy of H2S in regulating endothe-
lial activation. We next examined the expression of GFAP in brain sec-
tions of these animals as a measure of Astrocyte activation. As clearly
evident from Fig. 6B, HH-induced increase in the expression of GFAP
wasmarkedly abolished in animals receivingNaHS, prior to hypoxia ex-
posure, suggesting amelioration of HH-induced early Astrocyte activa-
tion under these conditions.
Since we had observed that the early perturbation of ‘Glio-Vascular
Units’ & BBB function (at day 3) precedes neuronal dysfunction in ourmodel system, we again performed assays to study structural and func-
tional integrity of BBB in H2S supplemented animals exposed to HH.We
ﬁrst performed confocal microscopy to establish Laminin–Aquaporin 4
co-localization (measure of Glio-Vascular structural integrity) in brain
sections of animals pretreated with NaHS, prior to 3 days of HH expo-
sure. As shown in Fig. 6C &D; in striking contrast to the animals exposed
to HHwithout NaHS, the Laminin–Aquaporin 4 signals co-localized sig-
niﬁcantly higher in the brain sections of animals receiving NaHS, prior
to HH. Notably, similar observations were made in Fluorescein extrava-
sation assay (Fig. 6E), where Fluorescein signal was signiﬁcantly lower
in hypoxic group (3 days), receiving NaHS and thus, suggesting preser-
vation of BBB functionality in these animals. We thus inferred that
NaHS-mediated maintenance of H2S levels prevented HH-induced loss
of Glio-Vascular function and homeostasis.
To investigate the effects of H2Smaintenance onneuro-physiological
functioning; we, next, performed Morris Water Maze and T-Maze tests
in the animals exposed to 7 days of hypobaric hypoxia, with/without
NaHS pretreatment. As shown in Fig. 6F–I, pre-treatment with NaHS
prevented spatial reference memory deﬁcit in response to 7 days of
HH exposure. Similar results were obtained in rewarded alternation
tasks studied by elevated T-maze assay (Fig. 6J). These results, taken
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Hypoxia conditions alleviates its patho-physiological effects on
memory.
We additionally tested if the preservation of neuro-physiological ef-
fects was mediated by prevention of neuronal apoptosis (described in
Fig. 1 for HH exposure). We studied the same in independent experi-
ments involving multiple technical approaches. The panels in Fig. 6K
show IHC staining for cleaved-Caspase 3 while those in Fig. 6L & M de-
pict ﬂow cytometry based analyses of intracellular cleaved-Caspase 3
(active form) expression and TUNEL assay in the cells isolated from hip-
pocampus of animals exposed to 7 days of HH, with or without NaHS
pretreatment. These experiments strongly suggested prevention of
HH-induced apoptosis of neuronal cells in animals pretreated with
NaHS.
The results described in this section, taken together, clearly sug-
gested that H2S is critical for brain vascular homeostasis during HH
and the maintenance of its levels, during these conditions, preserves
Glio-Vascular integrity, neuronal viability and thus, alleviation of HH-
induced patho-physiological effects in brain.
Fig. 7 schematically depicts theworking hypothesis, as inferred from
various spatio- temporal events deciphered from the current study, in-
tegrated to the established framework of speciﬁc units of function in
brain, Neuro-Vascular and Glio-Vascular units (see ﬁgure legend for
details).
4. Discussion
The present study addressed critical issues pertaining to the origin/
mechanism of neuro- pathological effects of Hypobaric Hypoxia and in-
terestingly, described a promising interventional strategy for preserving
Glio-Vascular homeostasis. Despite several decades of neurophysiolog-
ical research involving both human subjects and animal models, the
precise patho-etiology of chronic effects of high altitude (HA) on mem-
ory and cognition continued to remain elusive. The complexity arising
due to concomitant, spatio-temporal responses of heterogeneous
brain cell types—each having different threshold for adaptation to hyp-
oxia and responses to paracrine factors (due to systemic distress) in
circulation—posed a major limitation for mechanistic understanding of
this complex phenomenon. Our current study, employing an animal
model of Hypobaric Hypoxia and systems level analysis, rendered a
unique advantage in this regard. The time-series experiments have
proven supremacy over staticmeasurements for inferring andmodeling
dynamic biological processes (Bar-Joseph et al., 2012). The potential of
such datasets is however, harnessed to its fullest with the analysis as-
suming a holistic view such that the network of putative co-expressed
genes is deciphered on time dimension. The unbiased statistical
coexpression networks were therefore effective in distinguishing tem-
poral patterns of responses. Our study clearly indicated that the early
phase of responses to HH involved Glio-Vascular dysfunction, which
likely progressed to perturb neuronal processes during later durations.
In general, virtually all forms of pathophysiological conditions affecting
brain originate at a speciﬁc level in themodular Neuro-Vascular assem-
bly (involving cerebro- vasculature, astrocytes, neurons) and eventually
transmitted to other components in these ‘units of function’—central to
all neurological processes. Thus, identifying the origin of perturbation in
our study proved to be of unparalleled signiﬁcance in revealing a poten-
tial interventional approach targeting deleterious effects of HA.
Interestingly, the phenomenon deciphered from our model system
appears to be analogous to ﬁndings reported for non-lethal forms of
High Altitude Cerebral Edema (HACE) in human subjects. The tran-
scriptome signatures of brain at day 1 (post HH) in conjunction with
various histological and ultra structural evidences described in our
study (Figs. 3 & 4), unambiguously suggested cascade of events involving
vascular dysfunction/injury, inﬂammation and hemostatic responses.
Similar phenomenon of micro-hemorrhagic injury (conceivably involv-
ing vascular injury followed by hemostatic processes) has also beenobserved in high-resolution MRI studies involving human subjects diag-
nosed with non-lethal form of HACE (Kallenberg et al., 2008;
Schommer et al., 2013). It thus appears logical to conclude that perturba-
tion of brain vascular homeostasis during acute phases could be the com-
mon route to human ailments observed at HA and chronic neuro-
pathological effects of HH in our animal model. Further, in corollary,
this inference also underscores the relevance of the molecular circuitry
deciphered from our present study for general mechanistic reconstruc-
tion of brain responses to HA.
During recent years, certain working hypotheses had been put
forth to explain HA-induced loss of BBB integrity during severe clin-
ical conditions such as HACE (High Altitude Cerebral Edema). While
one proposition suggested likely perturbation of hemodynamics in
brain, originating from imbalance of cerebral inﬂow exceeding out-
ﬂow capacity, as a putative trigger of BBB disruption (Willmann
et al., 2014; Wilson et al., 2013, 2011, 2009); the other hypothesis
emphasized a vital role of soluble factors including VEGF, VEGFR
(Schoch et al., 2002; Tissot van Patot et al., 2005; Xu and
Severinghaus, 1998) and ROS (Patir et al., 2012) in increasing vascu-
lar permeability. Our present data set is particularly interesting for
HH (or HA)-induced vascular dysfunction and as discussed below, sug-
gests concomitant modulation of multiple, interacting biological
pathways—each capable of affecting vascular permeability. First, our
gene expression data strikingly revealed distinct networks/pathways in-
volved in regulation of cerebro-vascular tone. This included genes com-
posing signaling cascade downstream of Adenosine A2A receptor
(ADORA2A), Angiotensin II, Endothelin and Catecholamines (Adrenalin
and Noradrenalin) (Fig. 3 & Table 1). It thus appears likely that the resul-
tant of such vasomodulatory cues regulates CBF and brain perfusion dur-
ingHH. Second,we observed decreased levels of two key vasomodulatory
gaseousmediators (NO &H2S) during early phases of response to HH. In-
triguing, further, H2S levels appeared to be causally linked to those of NO,
and cGMP—a key secondmessenger known to regulate Calcium sensitiv-
ity/Vascular tone. These important observations, in conjunction with ac-
tual CBF measurements under various conditions (Fig. 5), likely indicate
insufﬁcient hypoxic cerebral autoregulation—in an H2S-dependent
manner—during hypobaric hypoxia. Third, the global gene expression sig-
natures at day 1, post HH, suggested up-regulation of VEGF transcript
along with distinct VEGF-responsive and interacting gene networks. As
noted above, besidesmodulating angiogenic response, VEGF signaling ap-
pears to increase vascular leakage in response to hypoxia (Schoch et al.,
2002). Fourth, the ‘Proteolytic imbalance’ under these conditions, as evi-
dent from basement membrane erosion and substrate zymography in
our study, can plausibly aggravate vascular leakage. This phenomenon
merits consideration since a critical role of proteases, including tPA,
Urokinase andMMPs, have been implicated for breakdown of ECMpro-
teins and resulting BBB dysfunction during ischemic injury (Hermann
and ElAli, 2012; Rosell and Lo, 2008; Yepes et al., 2009). Also, the degra-
dation of Laminin—in a plasmin/tPA-dependent manner—precedes
excitotoxicity damage to hippocampal neurons (Chen and Strickland,
1997). Finally, our array dataset was also reminiscent of increased ex-
pression of several pro-inﬂammatory mediators and pathways, known
to culminate in endothelial activation and weakening of barrier func-
tion. Though, within the limitations of our current dataset, it is difﬁcult
to examine the temporal contributions of individual processes during
loss of BBB integrity, these phenomena are likely to have cumulative,
‘feed forward’ inﬂuence on vascular permeability. We propose that
the resultant effects of such pathways govern the severity and extent
of vascular dysfunction during HH. In a recent report, interestingly, we
inferred a rather similar scheme of events from global gene expression
analysis in human individuals diagnosed with high altitude pulmonary
edema (HAPE)—another clinical condition, principally originating from
vascular dysfunction (Sharma et al., 2014). Taken together, vascular ho-
meostasis appears to constitute the Achilles heels of adaptation to high
altitude with unifying underlying mechanisms in multiple organ
systems.
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present study, the nature of early perturbation induced by HH does
not appear to be region-speciﬁc. Arguably, though, its magnitude and
manifestations may vary in individual regions owing to differences in
anatomical organization. Yet the most common patho-physiological
manifestation of HH includes loss of functions related to hippocampus
(memory and cognition). We suggest that such regio-speciﬁc effects
could arise due to intrinsic vulnerability of individual regions of brain
to BBB dysfunction. As an example, a likely consequence of loss of BBB
function would, arguably, be increase in concentration of Glutamate in
brain interstitial tissue. This key excitatory amino acid is present at a
concentration of ~100 μM in plasma and b1 μM in brain interstitial
ﬂuid (Abbott et al., 2006). The neurons—which are typically located 8–
20 μm away from brain capillaries (Abbott et al., 2006)—would thus
be exposed to excitotoxicity damage in the event of loss of BBB function.
In keeping with this proposition, the predominance of glutamatergic
neurons in hippocampus could explain its vulnerability to HH and at
least in part, effects of HH on memory (Koundal et al., 2014; Maiti
et al., 2008; Pulsinelli, 1985). Summarily, these arguments further sup-
port the possibility of ‘secondary’ damage to neurons during hypobaric
hypoxia-induced memory dysfunction and also, accentuate interven-
tional strategies aimed to preserve brain vascular homeostasis under
these settings.
It is increasingly being recognized that the triggers of disease in
neuro-degeneration may also provide cues for endogenous compensa-
tion and recovery (Arai et al., 2009; Lo, 2010). Hence, an effective strat-
egy should not only counteract the primary cause of degeneration but
also, complement the processes of endogenous regeneration and pres-
ervation under speciﬁc triggers (Lo, 2010). Consistentwith this hypoth-
esis as well, H2S augmentation strategy during HH appears distinctively
adept because of following reasons: 1) It is fundamentally amore potent
regulator of vascular dynamics due to greater diversity of targets and ef-
fects (both direct or indirect)—ranging from systemic, cyto-protective,
metabolic, biochemical and molecular (Li et al., 2011). Amongst the
two gaseous regulators (NO & H2S) of vascular tone (Coletta et al.,
2012; Yang et al., 2008), H2S seems to have occupied a unique niche. Be-
sides directly regulating vasoconstriction through the activation of
KATP channels (Zhao et al., 2001) (abundantly present in cerebral vas-
culature (Wang et al., 1997)), it regulates NO availability by regulating
eNOS activity (King et al., 2014) and also, maintenance of cGMP levels
through inhibition of PDE (Bucci et al., 2010). Furthermore, H2S has
been shown to protect against oxidative stress (Kimura and Kimura,
2004) and also, counteract the deleterious effects of electrophilic
byproducts of redox signaling (such as 8-nitro-cGMP) directly by elec-
trophile sulfhydration (Nishida et al., 2012). 2) Besides its vasculature-
speciﬁc effects, H2S directly exerts its effect on abluminal homeostasis
by modulating MMP 9 induced protease stress (Tyagi et al., 2010), Cal-
cium waves in Astrocytes (Nagai et al., 2004) and glial activation (Lee
et al., 2010). Possibly, these effects make it a better regulator of BBB
function and endows it anti-neuroinﬂammatory properties. 3) It ap-
pears to preserve neurons under pathological conditions arising due to
endogenous factors such as β-amyloid (Xuan et al., 2012), homocyste-
ine (Kamat et al., 2013; Li et al., 2014) and glutamate (Qu et al., 2008).
4) Most notably, H2S appears to promote proliferation and differentia-
tion of neural stem cells under hypoxic challenge (Liu et al., 2014).
Taken together, H2S signaling not only serves as a guardian against
NVU insult but also reinforces stimulus-dependent endogenous regen-
eration pathways, rendering itmore potent in curtailing pathological ef-
fects of HH.
Notably, the implications of these observations are plausibly of gen-
eral relevance and likely to ﬁnd application for other diseases originat-
ing from BBB dysfunction as well. Several pathological states of brain
including stroke, trauma, infection, pain, multiple sclerosis, HIV,
Alzheimer's disease, Parkinson's disease, Epilepsy and brain tumours in-
volve some degree of BBB breakdown and risk of ensuing secondary
damage to neurons (Abbott et al., 2006). Not surprisingly, therefore,strategies for promoting BBB restitution besides possible prevention of
its dysfunction during such clinical conditions present an important
clinical counteractive strategy. In view of unifying features of HH-
induced neuro-pathophysiology and said diseases of brain, we suggest
that the mechanisms and interventional approaches, such as H2S aug-
mentation, deciphered in context to HH would be of possible use for
preventing secondary damage to neurons during other pathological
states as well.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.03.002.
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